Decision: Favourable

Decisions Table

Study Title:

A multi-centre, single arm, open-label extension study to evaluate the long-term safety of GSK3511294 (Depemokimab) in adult and adolescent participants with severe asthma with an eosinophilic phenotype from studies 206713 or 213744

  • NREC Code:

    22-NREC-CT-128

  • Decision:

    Favourable

  • Meeting Date:

    27/07/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Dr Desmond Murphy

  • PI Institution:

    Cork University Hospital

  • Sponsor:

    GlaxoSmithKline Research & Development Limited

Scroll to Top